Lung Screen Uptake Trial: results from a single lung cancer screening round

The Lung Screen Uptake Trial tested a novel invitation strategy to improve uptake and reduce socioeconomic and smoking-related inequalities in lung cancer screening (LCS) participation. It provides one of the first UK-based ‘real-world’ LCS cohorts. Of 2012 invited, 1058 (52.6%) attended a ‘lung hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruparel, Mamta, Quaife, Samantha L, Dickson, Jennifer L, Horst, Carolyn, Tisi, Sophie, Hall, Helen, Taylor, Magali, Ahmed, Asia, Shaw, Penny, Burke, Stephen, Soo, May-Jan, Nair, Arjun, Devaraj, Anand, Sennett, Karen, Duffy, Stephen W, Navani, Neal, Bhowmik, Angshu, Baldwin, David R, Janes, Sam M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509385/
https://www.ncbi.nlm.nih.gov/pubmed/32759387
http://dx.doi.org/10.1136/thoraxjnl-2020-214703
Descripción
Sumario:The Lung Screen Uptake Trial tested a novel invitation strategy to improve uptake and reduce socioeconomic and smoking-related inequalities in lung cancer screening (LCS) participation. It provides one of the first UK-based ‘real-world’ LCS cohorts. Of 2012 invited, 1058 (52.6%) attended a ‘lung health check’. 768/996 (77.1%) in the present analysis underwent a low-dose CT scan. 92 (11.9%) and 33 (4.3%) participants had indeterminate pulmonary nodules requiring 3-month and 12-month surveillance, respectively; 36 lung cancers (4.7%) were diagnosed (median follow-up: 1044 days). 72.2% of lung cancers were stage I/II and 79.4% of non-small cell lung cancer had curative-intent treatment.

Ejemplares similares